WVE - Wave Life Sciences - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

400.6M

Cash

173M

Avg Qtr Burn

-2.705M

Short % of Float

8.03%

Insider Ownership

21.22%

Institutional Own.

71.68%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
WVE-N531 Details Duchenne muscular dystrophy	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WVE-003 Details Huntington's disease	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WVE-120101 (SNP1) Details Huntington's disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WVE-120102 (SNP2) Details Huntington's disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WVE-004 Details Amyotrophic lateral sclerosis, Frontotemporal dementia with GRN mutations	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.